JNJ

192.08

-0.38%↓

ABT

126.36

-1.14%↓

MDT

94.19

-1.71%↓

VEEV

291.41

+0.69%↑

A

147.65

+1.19%↑

JNJ

192.08

-0.38%↓

ABT

126.36

-1.14%↓

MDT

94.19

-1.71%↓

VEEV

291.41

+0.69%↑

A

147.65

+1.19%↑

JNJ

192.08

-0.38%↓

ABT

126.36

-1.14%↓

MDT

94.19

-1.71%↓

VEEV

291.41

+0.69%↑

A

147.65

+1.19%↑

JNJ

192.08

-0.38%↓

ABT

126.36

-1.14%↓

MDT

94.19

-1.71%↓

VEEV

291.41

+0.69%↑

A

147.65

+1.19%↑

JNJ

192.08

-0.38%↓

ABT

126.36

-1.14%↓

MDT

94.19

-1.71%↓

VEEV

291.41

+0.69%↑

A

147.65

+1.19%↑

Search

Intuitive Surgical Inc

Chiusa

SettoreSettore sanitario

551.23 4.64

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

525.35

Massimo

552.26

Metriche Chiave

By Trading Economics

Entrata

-40M

664M

Vendite

187M

2.4B

P/E

Media del settore

62.123

37.461

Margine di Profitto

27.221

Dipendenti

15,638

EBITDA

268M

987M

Raccomandazioni

By TipRanks

Raccomandazioni

Fortemente da comprare

Previsioni per 12 mesi

+16.06% upside

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-21B

164B

Apertura precedente

546.59

Chiusura precedente

551.23

Notizie sul Sentiment di mercato

By Acuity

23%

77%

127 / 371 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Weak Bearish Evidence

Intuitive Surgical Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

21 ott 2025, 23:55 UTC

Azioni calde

Stocks to Watch: DraftKings, Texas Instruments, Intuitive Surgical, Pegasystems

21 ott 2025, 21:14 UTC

Utili
I principali Market Mover

Intuitive Surgical 3Q Profit, Sales Jump, Sees Higher da Vinci Procedure Growth -- Update

21 ott 2025, 20:38 UTC

Utili

Intuitive Surgical 3Q Profit, Sales Jump, Sees Higher da Vinci Procedure Growth

22 lug 2025, 21:13 UTC

Utili

Intuitive Surgical Logs Higher Profit, Revenue in 2Q

22 apr 2025, 20:55 UTC

Utili

Intuitive Surgical Reports Higher 1Q Profit, Warns of Tariff Hit to Margins

22 ott 2025, 15:42 UTC

Utili

Intuitive Surgical Stock Jumps on Earnings. Its Newest Surgical Robot Is Going Gangbusters. -- Barrons.com

22 ott 2025, 12:34 UTC

Utili

Intuitive Surgical Stock Surges. Earnings Show It Can Maintain 'Bellwether Medtech Growth Status.' -- Barrons.com

22 ott 2025, 11:49 UTC

Utili

Intuitive Surgical Stock Surges. Earnings Show It Can Maintain 'Bellwether Medtech Growth Status.' -- Barrons.com

21 ott 2025, 20:08 UTC

Utili

Intuitive Surgical: Worldwide Da Vinci Procedure Growth of Approximately 17% to 17.5% in 2025, Compared to 17% in 2024 >ISRG

21 ott 2025, 20:08 UTC

Utili

Intuitive Surgical: Non-GAAP Gross Profit Margin to Be Within a Range of 67% and 67.5% of Rev in 2025, Compared to 69.1% in 2024 >ISRG

21 ott 2025, 20:05 UTC

Utili

Intuitive Surgical 3Q Rev $2.51B >ISRG

21 ott 2025, 20:05 UTC

Utili

Intuitive Surgical 3Q Net $704.4M >ISRG

21 ott 2025, 20:05 UTC

Utili

Intuitive Surgical 3Q Adj EPS $2.40 >ISRG

21 ott 2025, 20:05 UTC

Utili

Intuitive Surgical 3Q Da Vinci Surgical Systems Shipped 427.00 >ISRG

21 ott 2025, 20:05 UTC

Utili

Intuitive Surgical 3Q EPS $1.95 >ISRG

22 lug 2025, 20:14 UTC

Utili

Intuitive Surgical Sees FY25 Non-GAAP Gross Profit Margin to Be Within Range of 66% and 67% >ISRG

22 lug 2025, 20:13 UTC

Utili

Intuitive Surgical Sees FY25 Worldwide Da Vinci Procedure Growth of 15.5% to 17% >ISRG

22 lug 2025, 20:13 UTC

Utili

Intuitive Surgical Grew Da Vinci Surgical System Installed Base to 10,488 Systems as of June 30 >ISRG

22 lug 2025, 20:05 UTC

Utili

Intuitive Surgical 2Q Net $658.4M >ISRG

22 lug 2025, 20:05 UTC

Utili

Intuitive Surgical 2Q Da Vinci Surgical Systems Shipped 395.00 >ISRG

22 lug 2025, 20:05 UTC

Utili

Intuitive Surgical 2Q Rev $2.44B >ISRG

22 lug 2025, 20:05 UTC

Utili

Intuitive Surgical 2Q Adj EPS $2.19 >ISRG

22 lug 2025, 20:05 UTC

Utili

Intuitive Surgical 2Q EPS $1.81 >ISRG

22 apr 2025, 20:13 UTC

Utili

Intuitive Surgical Sees FY25 Worldwide Da Vinci Procedure Growth of 15% to 17%

22 apr 2025, 20:05 UTC

Utili

Intuitive Surgical 1Q EPS $1.92 >ISRG

22 apr 2025, 20:05 UTC

Utili

Intuitive Surgical 1Q Adj EPS $1.81 >ISRG

22 apr 2025, 20:05 UTC

Utili

Intuitive Surgical 1Q Net $698.4M >ISRG

22 apr 2025, 20:05 UTC

Utili

Intuitive Surgical 1Q Da Vinci Surgical Systems Shipped 367.00 >ISRG

22 apr 2025, 20:05 UTC

Utili

Intuitive Surgical 1Q Rev $2.25B >ISRG

24 gen 2025, 21:17 UTC

Utili

Why Intuitive Surgical Crumbled Despite Its Upbeat Fourth-Quarter Report -- IBD

Confronto tra pari

Modifica del prezzo

Intuitive Surgical Inc Previsione

Obiettivo di Prezzo

By TipRanks

16.06% in crescita

Previsioni per 12 mesi

Media 611.68 USD  16.06%

Alto 685 USD

Basso 440 USD

Basato su 20 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Intuitive Surgical Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

20 ratings

16

Acquista

3

Mantieni

1

Vendi

Punteggio Tecnico

By Trading Central

514.59 / 539.05Supporto e resistenza

A breve termine

Weak Bearish Evidence

A termine intermedio

Weak Bullish Evidence

A lungo termine

Strong Bullish Evidence

Sentiment

By Acuity

127 / 371 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove rialziste molto forti

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sopra la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Intuitive Surgical Inc

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
help-icon Live chat